Saltar al contenido
Merck

[Serum cholesterol ester level in patients with ischemic heart disease and liver disease].

Kardiologiia (1984-10-01)
N P Odushko, N F Muliar
RESUMEN

The blood serum of coronary and liver patients was shown to display a similar increase in the relative levels of cholesterololeate and a some what less marked elevation in the content of cholesterol esters with saturated fatty acids. The cholesterollinoleate concentration was enhanced in patients with viral hepatitis and decreased in coronary heart disease patients. The differences were especially distinct in changes of the relative content of cholesterolarachidonate and esters of cholesterol with eicosopentaen acid. Cholesterolarachidonate levels showed no changes in CHD whereas they lowered markedly in various diseases of the liver and biliary tracts. The role of changes in the relative content of cholesterol ester fractions in the genesis of atherosclerosis in patients with liver diseases is discussed.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Cholesteryl arachidonate, ≥95% (HPLC; detection at 205 nm), viscous liquid